🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

We enjoyed excellent participation from the audience at last week's UK Platform for Nucleic Acid Therapies- UPNAT Symposium. Our two panels (1- target selection for #raredisease, and 2- #clinicaltrials and regulatory pathway) in particular generated thoughtful & useful discussion. Rare Disease Research UK Medical Research Council National Institute for Health and Care Research

Join the UK Platform for Nucleic Acid Therapies- UPNAT team! Now hiring: our candidate will have a PhD degree in biomedical sciences or closely related areas, with strong knowledge & skillset in bioinformatics. Preclinical RNA therapy drug development (ASO, siRNA, mRNA) are highly desired. ucl.ac.uk/work-at-ucl/se…

Now to build on the momentum of the recent UK Platform for Nucleic Acid Therapies- UPNAT Symposium, with the help of our partners across the UK and beyond. With special thanks to Oligonucleotide Therapeutics Society who supported PPIE at the event with their generous grant: oligotherapeutics.org/ots-local-regi…

UPNAT Director Haiyan Zhou Dr Haiyan Zhou will be speaking tomorrow alongside UK DRI Director Mina Ryten Mina Ryten at the Genomics England Summit about the UK Platform for Nucleic Acid Therapies- UPNAT and enhancing rare disease treatment: genomicsresearchsummit.co.uk

Buzzing crowd at yesterday's Genomics England Research Summit, where Mina Ryten contributed to the "Therapeutic Innovations and Trials" session with an introduction to our UK Platform for Nucleic Acid Therapies- UPNAT. Genomics England #RareDisease #gers2024

Join us for an insightful webinar on "A Nucleic Acid Approach to Antibody Therapeutics" on July 18th. Dr. John Chaput will explore innovative pathways for democratizing antibody therapeutics using threomers. Register now: oligotherapeutics.org/a-nucleic-acid… #ots #webinar #nucleicacid

📢Our 2nd Annual Conference is happening on 25th March 2025! Mark your calendars and join us in #Manchester 🔔Stay tuned for more updates! #RDRUKcon #RareDiseaseResearch #raredisease #Livingrare #hopeforrare

Excellent speakers lined up for the Oxford-Harrington Rare Disease Centre  Symposium later this month (including UK Platform for Nucleic Acid Therapies- UPNAT Director Haiyan Zhou) Registration is open: oxfordharrington.org/events-news/ev… #RareDiseases Dr Haiyan Zhou Oxford-Harrington Rare Disease Centre

UPNAT Node partner Prof Carlo Rinaldi chairs an excellent session at the #OxfordHarrington2024 Rare Disease Centre Symposium. Full agenda here: oxfordharrington.org/events-news/ev… Carlo Rinaldi Oxford-Harrington Rare Disease Centre University of Oxford UK Platform for Nucleic Acid Therapies- UPNAT

We shared the excitement as Haiyan Zhou Dr Haiyan Zhou presented an update on her research as Harrington Scholar Harrington Discovery Institute. And appreciated the introduction to our UK Platform for Nucleic Acid Therapies- UPNAT! #OxfordHarrington2024 Oxford-Harrington Rare Disease Centre Rare Disease Research UK #RareDisease

Impressive work by the Dutch Center for RNA Therapeutics! Thanks to Marlen Lauffer for the opportunity to participate in this ASO guideline development, with UK Platform for Nucleic Acid Therapies- UPNAT co-authors Alice Davidson and Mina Ryten medrxiv.org/content/10.110… #DCRT

AnnemiekeAartsma-Rus Tim Yu UK Platform for Nucleic Acid Therapies- UPNAT Danique Beijer Aubrie The guidelines are accompanied by training videos and test variants for practicing assessments. All videos are available via the N1C YouTube Channel. youtube.com/@N1Collaborati…

An interesting paper to contextualise the recent published guidelines by the Dutch Center for RNA Therapeutics journals.sagepub.com/doi/full/10.11… AnnemiekeAartsma-Rus Marlen Lauffer @roon_mom #raredisease

Join the UK Platform for Nucleic Acid Therapies- UPNAT team! Applications for the Child Health Research (CHR) PhD Studentships for 25/26 are open. Deadline for students to apply is 09:00 Friday 13th December. ucl.ac.uk/child-health/d…

The Oxford-Harrington Rare Disease Centre has announced inaugural 2024 Rare Disease Scholar award recipients, which includes two members of the UK Platform for Nucleic Acid Therapies- UPNAT team. Well done Haiyan Zhou and Carlo Rinaldi on this notable achievement! Oxford-Harrington Rare Disease Centre Dr Haiyan Zhou Carlo Rinaldi Rare Disease Research UK

Congrats to Carlo Rinaldi Carlo Rinaldi, awarded title of Professor of Molecular & Translational Neuroscience University of Oxford Institute of Developmental & Regenerative Medicine. Carlo is UK Platform for Nucleic Acid Therapies- UPNAT PI, streamlining NAT clinical trials & regulatory approval. idrm.ox.ac.uk/news-events/ne…

UPNAT Director Haiyan Zhou is keynote speaker at the upcoming Cambridge Chem&Bio Seminar on Nucleic Acid Research. Dr Haiyan Zhou UK Platform for Nucleic Acid Therapies- UPNAT Space is available on 14 Dec "whether you're a student, researcher, or simply curious about the field", book here: eventbrite.co.uk/e/12th-cambrid…

12 PhDs on Antisense oligonucleotide #research to foster the full therapeutic potential of antisense technology across tissues euraxess.ec.europa.eu/jobs/296420 11 posts across Europe, the other at UCL under UK Platform for Nucleic Acid Therapies- UPNAT Director Haiyan Zhou Dr Haiyan Zhou

Today, on #RareDiseaseDay, we are happy to share the Department of Health and Social Care newly published 2025 England Rare Disease action plan - exciting work ahead for the UK Platform for Nucleic Acid Therapies- UPNAT! gov.uk/government/pub… #RareDiseaseDay #RareDiseaseDay2025 #RareDisease